J&J’s big blockbuster hopeful esketamine scores high for major depression — but side effects haunt results
Can a horse tranquilizer and notorious party drug be reinvented as a safe and effective breakthrough therapy to swiftly treat major depression and suicidal thinking?
J&J $JNJ has been working on that task for years and is now hammering away at a pivotal late-stage program. This week they’re rolling out some detailed Phase II results that underscore the potential, as well as the problems, that seem inextricably linked to this drug.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.